Article

Integrative Omics for Informed Drug Repurposing: Targeting CNS Disorders

2020-04-25

Abstract excerpt

The treatment of CNS disorders, and in particular psychiatric illnesses, lacks disease-altering therapeutics for many conditions. This is likely due to regulatory challenges involving the high cost and slow-pace of drug development for CNS disorders as well as due to limited understanding of disease causality. Repurposing drugs for new indications have lower cost and shorter development timeline compared to that o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b2e1e1d0-81b6-5090-b234-22ba964ddd26
DOI: 10.1101/2020.04.24.060392

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrative Omics for Informed Drug Repurposing: Targeting CNS DisordersDOI 10.1101/2020.04.24.060392Read

Repurposing of Drugs in Autoimmune Diseases: From Serendipity to System ResetSemantic proximity Read

Drug REpurposing using AI/ML tools - for Rare Diseases (DREAM-RD): A case study with Fragile X Syndrome (FXS)Semantic proximity Read

The Drug Repurposing Encyclopedia (DRE): a web server for systematic drug repurposing across 20 organismsSemantic proximity Read

Drug Repurposing in Rare Diseases: An Integrative Study of Drug Screening and Transcriptomic Analysis in Nephropathic CystinosisSemantic proximity Read

Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databasesSemantic proximity Read

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read

Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platformSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

When GWAS meets the Connectivity Map: drug repositioning for seven psychiatric disordersSemantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization StudiesSemantic proximity Read

Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesSemantic proximity Read